SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-21-001089
Filing Date
2021-11-04
Accepted
2021-11-04 07:30:24
Documents
13
Period of Report
2021-11-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 28168
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 47459
  Complete submission text file 0001079973-21-001089.txt   259684

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE opgn-20211104.xsd EX-101.SCH 3018
4 XBRL LABEL FILE opgn-20211104_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE opgn-20211104_pre.xml EX-101.PRE 22354
6 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3563
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 211378013
SIC: 8071 Services-Medical Laboratories